Cargando…

Improved outcomes from HIV/TB co-infection in Singapore following a switch to earlier anti-retroviral therapy

INTRODUCTION: Recent clinical trials have provided clear evidence to support early anti-retroviral therapy (ART) in patients with HIV/TB co-infection and low CD4 counts. We investigated how this has changed treatment and outcomes in Singapore. MATERIALS AND METHODS: A retrospective review was perfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Barnaby, Marimuthu, Kalisvar, Suay Hong, Gan, Yee Sin, Leo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P092
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224935/ https://www.ncbi.nlm.nih.gov/pubmed/25394128 http://dx.doi.org/10.7448/IAS.17.4.19624

Ejemplares similares

Symptomatic Myocarditis After Pfizer Covid-19 Vaccination
por: Patel, Kirtan, et al.
Publicado: (2023)

Troubles mnésiques persistants post-COVID-19 : intérêt de la recherche des anti-SARS-CoV-2 dans le LCR couplée à la spectro-IRM cérébrale ?
por: Zaouzaou, L., et al.
Publicado: (2022)

COVID-19 et épidémie de pseudo-engelures : y a-t-il un lien ?
por: Lesort, C., et al.
Publicado: (2020)

O IMPACTO DA PANDEMIA DE CORONAVÍRUS (COVID‐19) NA BUSCA POR CONHECIMENTO SOBRE A PREVENÇÃO DE INFECÇÕES: GOOGLE TRENDS
por: Carril, Gabriela Teodoro, et al.
Publicado: (2021)

The absolute lymphocyte count accurately estimates CD4 counts in HIV-infected adults with virologic suppression and immune reconstitution
por: Young, Barnaby, et al.
Publicado: (2014)

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
por: Sekaggya Wiltshire, Christine, et al.
Publicado: (2014)

A case of imported Monkeypox in Singapore
por: Ng, Oon Tek, et al.
Publicado: (2019)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study
por: Rokx, Casper, et al.
Publicado: (2014)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
por: Fisher, Martin, et al.
Publicado: (2014)

Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc
por: Bernal, Enrique, et al.
Publicado: (2014)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study
por: Gagliardini, Roberta, et al.
Publicado: (2014)

Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study
por: Portilla, Joaquín, et al.
Publicado: (2014)

Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis
por: Stellbrink, Hans-Juergen, et al.
Publicado: (2014)

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre
por: Borghetti, Alberto, et al.
Publicado: (2014)

ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study
por: Podzamczer, Daniel, et al.
Publicado: (2014)

Predictors of emphysema progression in HIV-positive patients
por: Guaraldi, Giovanni, et al.
Publicado: (2014)

Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera(®)). Efficacy and safety analysis. GeSida Study 8114
por: Pérez-Hernández, Isabel A, et al.
Publicado: (2014)

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study
por: Pérez Valero, Ignacio, et al.
Publicado: (2014)

Burden of subclinical heart and lung disease detected on thoracic CT scans of HIV patients on HAART
por: Zona, Stefano, et al.
Publicado: (2014)

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL
por: Dentone, Chiara, et al.
Publicado: (2014)

Switching to nevirapine-based regimens after undetectable viral load is not associated with increased risk of discontinuation due to toxicity
por: Patterson, Patricia, et al.
Publicado: (2014)

Determinants of HIV outpatient service utilization according to HIV parameters
por: Di Carlo, Paola, et al.
Publicado: (2014)

Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Dokuzoguz, Basak, et al.
Publicado: (2014)

Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trials
por: Reeves, Iain, et al.
Publicado: (2014)

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression
por: Llibre, Josep M, et al.
Publicado: (2014)

Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study
por: Carrero-Gras, Ana, et al.
Publicado: (2014)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2014)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Acute retroviral syndrome mimincs dengue in Singapore, a dengue endemic country
por: Tan, JH, et al.
Publicado: (2012)

Recreational drugs and HIV in Europe: current use of recreational drugs and principal HIV guidelines related recommendations
por: Garin Escriva, Noe, et al.
Publicado: (2014)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Targeted destruction of HIV-positive cells
por: Sharma, Jyoti R, et al.
Publicado: (2014)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study
por: Bianco, Claudia, et al.
Publicado: (2014)

Outcomes of initial antiretroviral treatment (ART) among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Korten, Volkan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sl7k4b70ejcel5rmdu1hi63f82